Detlef Schuppan

Last updated

Detlef Schuppan (born 9 August 1954 in Essen, West Germany) is a German biochemist and physician. He focuses on the diagnosis and treatment of coeliac disease and wheat sensitivity, fibrotic liver diseases and the immunology of chronic diseases and cancer. He is the director of the Institute of Translational Immunology and a professor of internal medicine, gastroenterology, and hepatology at the Medical Center of the Johannes Gutenberg University of Mainz in Germany. He directs the outpatient clinic for coeliac disease and small intestinal diseases. He is also a professor of medicine and a senior visiting scientist at Harvard Medical School.

Contents

Early life and education

Schuppan was born on 9 August 1954 in Essen, Germany, to Helga Schuppan (née Pahnke) and Senate President Dr. Walther Schuppan. He studied chemistry and medicine at the Ludwig Maximilian University of Munich, and medicine at the Philipp University of Marburg and the Free University of Berlin. In 1982, he received a Ph.D. from the Max Planck Institute of Biochemistry in Martinsried, outside Munich, where he studied the primary structure of basement membrane collagen. In 1986, he received his M.D. from the Free University of Berlin, and three years later, he received his second Ph.D. in medicine summa cum laude after identifying and characterizing undulin/collagen type XIV. He then habilitated in biochemistry (1992) and internal medicine (1996) at the Free University of Berlin. He earned his board certification for internal medicine in 1993 and gastroenterology in 1996.

He is married to Dr. Kristin Gisbert-Schuppan, a psychologist. He has three daughters and a son.

Work

From 1997 to 2004, Schuppan worked as a professor, chief medical consultant, and deputy medical director in the Department of Medicine at the Friedrich Alexander University of Erlangen-Nuremberg. From 2004 to 2010, he was a lecturer, first associate, and later full professor of medicine and clinical attending physician/consultant in the Division of Gastroenterology and Hepatology at Beth Israel Deaconess Medical Center, part of Harvard Medical School. In 2011, he became director of the coeliac disease and fibrosis center at the University of Mainz and a senior visiting scientist at Beth Israel Deaconess. Since 2013, he has been the director of the Institute of Translational Immunology at the University of Mainz.

Schuppan has had visiting professorships at Columbia University, Yale University, Duke University, the University of Maryland, the Mayo Clinic, the Weizmann Institute of Science, and the University of California at Los Angeles and San Diego.

His clinical work and research are focused on the cellular and molecular mechanisms of chronic inflammatory diseases and the translation of these findings into clinical practice. He has helped develop novel diagnostic tools and therapies for inflammatory and fibrotic (scarring) diseases of the liver (cirrhosis), intestine, and other organs, and for coeliac disease, non-coeliac/non-allergy gluten sensitivity, and associated autoimmune and systemic diseases. He has researched the role of the immune system in the defense against cancer, especially of the liver and the gastrointestinal tract, and the role of nutrition in autoimmune and metabolic diseases, especially non-alcoholic fatty liver disease and Type 2 diabetes. His focus is on the development of targeted and individualized therapies—based, for example, on therapeutic nanoparticles [1] as drug carriers in combination with the development of specific disease biomarkers.

Key achievements

Key publications

Schuppan has authored more than 70 book chapters and more than 400 PubMed-listed scientific publications. [8]

He has edited several medical research books and is associate editor of high-ranking scientific journals like Gastroenterology, Journal of Hepatology, American Journal of Physiology and Journal of Clinical Investigation . Since 2011, he has been chair of the Scientific Council of the German Coeliac Society. [9] Schuppan is the only German physician and scientist who has been a full professor of medicine both in the United States and in Germany.

Awards and memberships

Awards (selection)

Memberships (selection)

Original research contributions and cooperations

Other websites

Curriculum vitae:

Coeliac disease/wheat sensitivity:

Related Research Articles

<span class="mw-page-title-main">Gluten</span> Group of cereal grain proteins

Gluten is a structural protein naturally found in certain cereal grains. Although "gluten" often only refers to wheat proteins, in medical literature it refers to the combination of prolamin and glutelin proteins naturally occurring in all grains that have been proved capable of triggering celiac disease. These include any species of wheat, barley, rye and some oat cultivars, as well as any cross hybrids of these grains. Gluten makes up 75–85% of the total protein in bread wheat.

<span class="mw-page-title-main">Coeliac disease</span> Autoimmune disorder that results in a reaction to gluten

Coeliac disease or celiac disease is a long-term autoimmune disorder, primarily affecting the small intestine, where individuals develop intolerance to gluten, present in foods such as wheat, rye and barley. Classic symptoms include gastrointestinal problems such as chronic diarrhoea, abdominal distention, malabsorption, loss of appetite, and among children failure to grow normally. This often begins between six months and two years of age. Non-classic symptoms are more common, especially in people older than two years. There may be mild or absent gastrointestinal symptoms, a wide number of symptoms involving any part of the body, or no obvious symptoms. Coeliac disease was first described in childhood; however, it may develop at any age. It is associated with other autoimmune diseases, such as Type 1 diabetes mellitus and Hashimoto's thyroiditis, among others.

<span class="mw-page-title-main">Irritable bowel syndrome</span> Functional gastrointestinal disorder

Irritable bowel syndrome (IBS) is a "disorder of gut-brain interaction" characterized by a group of symptoms that commonly include abdominal pain and or abdominal bloating and changes in the consistency of bowel movements. These symptoms may occur over a long time, sometimes for years. IBS can negatively affect quality of life and may result in missed school or work (absenteeism) or reduced productivity at work (presenteeism). Disorders such as anxiety, major depression, and chronic fatigue syndrome are common among people with IBS.

<span class="mw-page-title-main">Autoimmune hepatitis</span> Chronic, autoimmune disease of the liver

Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed. Common initial symptoms may include fatigue, nausea, muscle aches, or weight loss or signs of acute liver inflammation including fever, jaundice, and right upper quadrant abdominal pain. Individuals with autoimmune hepatitis often have no initial symptoms and the disease may be detected by abnormal liver function tests and increased protein levels during routine bloodwork or the observation of an abnormal-looking liver during abdominal surgery.

<span class="mw-page-title-main">Gluten-free diet</span> Diet excluding proteins found in wheat, barley, and rye

A gluten-free diet (GFD) is a nutritional plan that strictly excludes gluten, which is a mixture of proteins found in wheat, as well as barley, rye, and oats. The inclusion of oats in a gluten-free diet remains controversial, and may depend on the oat cultivar and the frequent cross-contamination with other gluten-containing cereals.

<span class="mw-page-title-main">Gliadin</span>

Gliadin is a class of proteins present in wheat and several other cereals within the grass genus Triticum. Gliadins, which are a component of gluten, are essential for giving bread the ability to rise properly during baking. Gliadins and glutenins are the two main components of the gluten fraction of the wheat seed. This gluten is found in products such as wheat flour. Gluten is split about evenly between the gliadins and glutenins, although there are variations found in different sources.

<span class="mw-page-title-main">Liver biopsy</span>

Liver biopsy is the biopsy from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.

The specific carbohydrate diet (SCD) is a restrictive diet originally created to manage celiac disease; it limits the use of complex carbohydrates. Monosaccharides are allowed, and various foods including fish, aged cheese and honey are included. Prohibited foods include cereal grains, potatoes and lactose-containing dairy products. It is a gluten-free diet since no grains are permitted.

<span class="mw-page-title-main">Tissue transglutaminase</span> Protein-coding gene in the species Homo sapiens

Tissue transglutaminase is a 78-kDa, calcium-dependent enzyme of the protein-glutamine γ-glutamyltransferases family. Like other transglutaminases, it crosslinks proteins between an ε-amino group of a lysine residue and a γ-carboxamide group of glutamine residue, creating an inter- or intramolecular bond that is highly resistant to proteolysis. Aside from its crosslinking function, tTG catalyzes other types of reactions including deamidation, GTP-binding/hydrolyzing, and isopeptidase activities. Unlike other members of the transglutaminase family, tTG can be found both in the intracellular and the extracellular spaces of various types of tissues and is found in many different organs including the heart, the liver, and the small intestine. Intracellular tTG is abundant in the cytosol but smaller amounts can also be found in the nucleus and the mitochondria. Intracellular tTG is thought to play an important role in apoptosis. In the extracellular space, tTG binds to proteins of the extracellular matrix (ECM), binding particularly tightly to fibronectin. Extracellular tTG has been linked to cell adhesion, ECM stabilization, wound healing, receptor signaling, cellular proliferation, and cellular motility.

<span class="mw-page-title-main">Non-alcoholic fatty liver disease</span> Excessive fat buildup in the liver not caused by alcohol use

Non-alcoholic fatty liver disease (NAFLD), also known as metabolic (dysfunction) associated fatty liver disease (MAFLD), is excessive fat build-up in the liver without another clear cause such as alcohol use. There are two types; non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), with the latter also including liver inflammation. Non-alcoholic fatty liver is less dangerous than NASH and usually does not progress to NASH. When NAFL does progress to NASH, it may eventually lead to complications such as cirrhosis, liver cancer, liver failure, or cardiovascular disease.

<span class="mw-page-title-main">Sheila Sherlock</span> British physician, hepatologist and educator

Dame Sheila Patricia Violet Sherlock DBE, FRCP FRCPE FRS HFRSE FMGA FCRGA was a British physician and medical educator who is considered the major 20th-century contributor to the field of hepatology.

<span class="mw-page-title-main">Gluten-related disorders</span> Set of diseases caused by gluten exposure

Gluten-related disorders is the term for the diseases triggered by gluten, including celiac disease (CD), non-celiac gluten sensitivity (NCGS), gluten ataxia, dermatitis herpetiformis (DH) and wheat allergy. The umbrella category has also been referred to as gluten intolerance, though a multi-disciplinary physician-led study, based in part on the 2011 International Coeliac Disease Symposium, concluded that the use of this term should be avoided due to a lack of specificity.

Gluten-sensitive enteropathy–associated conditions are comorbidities or complications of gluten-related gastrointestinal distress. GSE has key symptoms typically restricted to the bowel and associated tissues; however, there are a wide variety of associated conditions. These include bowel disorders, eosinophilic gastroenteritis and increase with coeliac disease (CD) severity. With some early onset and a large percentage of late onset disease, other disorders appear prior to the coeliac diagnosis or allergic-like responses markedly increased in GSE. Many of these disorders persist on a strict gluten-free diet, and are thus independent of coeliac disease after triggering. For example, autoimmune thyroiditis is a common finding with GSE.

Anti-transglutaminase antibodies (ATA) are autoantibodies against the transglutaminase protein. Antibodies serve an important role in the immune system by detecting cells and substances that the rest of the immune system then eliminates. These cells and substances can be foreign and also can be produced by the body. Antibodies against the body's own products are called autoantibodies. Autoantibodies can sometimes errantly be directed against healthy portions of the organism, causing autoimmune diseases.

The immunochemistry of Triticeae glutens is important in several inflammatory diseases. It can be subdivided into innate responses, class II mediated presentation, class I mediated stimulation of killer cells, and antibody recognition. The responses to gluten proteins and polypeptide regions differs according to the type of gluten sensitivity. The response is also dependent on the genetic makeup of the human leukocyte antigen genes. In gluten sensitive enteropathy, there are four types of recognition, innate immunity, HLA-DQ, and antibody recognition of gliadin and transglutaminase. With idiopathic gluten sensitivity only antibody recognition to gliadin has been resolved. In wheat allergy, the response pathways are mediated through IgE against other wheat proteins and other forms of gliadin.

FODMAPs or fermentable oligosaccharides, disaccharides, monosaccharides, and polyols are short chain carbohydrates that are poorly absorbed in the small intestine and are prone to absorb water and ferment in the colon. They include short chain oligosaccharide polymers of fructose (fructans) and galactooligosaccharides, disaccharides (lactose), monosaccharides (fructose), and sugar alcohols (polyols), such as sorbitol, mannitol, xylitol, and maltitol. Most FODMAPs are naturally present in food and the human diet, but the polyols may be added artificially in commercially prepared foods and beverages.

Non-celiac gluten sensitivity (NCGS) or gluten sensitivity is "a clinical entity induced by the ingestion of gluten leading to intestinal and/or extraintestinal symptoms that improve once the gluten-containing foodstuff is removed from the diet, and celiac disease and wheat allergy have been excluded".

<span class="mw-page-title-main">Alessio Fasano</span>

Alessio Fasano is an Italian-born medical doctor, pediatric gastroenterologist and researcher. He currently holds many roles, including professor of pediatrics at Harvard Medical School and professor of nutrition at Harvard T.H. Chan School of Public Health, both in Boston. He serves as director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children (MGHfC) and co-director of the Harvard Medical School Celiac Research Program. In addition, he is director of the Mucosal Immunology and Biology Research Center at MGHfC, where he oversees a research program with approximately 50 scientists and staff researching a variety of acute and chronic inflammatory diseases, including cystic fibrosis, celiac disease, enteric infections and necrotizing enterocolitis. A common theme of these programs is the study of the emerging role of the gut microbiome in health and disease. Fasano is also the scientific director of the European Biomedical Research Institute of Salerno (EBRIS) in Italy. Along with these leadership positions, he is a practicing outpatient clinician in pediatric gastroenterology and nutrition and the division chief.

The gluten challenge test is a medical test in which gluten-containing foods are consumed and (re-)occurrence of symptoms is observed afterwards to determine whether and how much a person reacts to these foods. The test may be performed in people with suspected gluten-related disorders in very specific occasions and under medical supervision, for example in people who had started a gluten-free diet without performing duodenal biopsy.

Carlo Catassi, is an Italian gastroenterologist, epidemiologist, and researcher. He is notable for international studies on the epidemiology of the celiac disease. He is Head of the Department of Pediatrics at the Università Politecnica delle Marche, Ancona, Italy; Visiting Scientist at Massachusetts General Hospital in Boston, Massachusetts, United States; and 2013-2016 President of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). His research also includes contributions to understanding the clinical spectrum of celiac disease and other gluten-related disorders.

References

  1. University of Mainz: Nanodimensional polymer therapeutics for tumor therapy. Retrieved 05 August 2014
  2. W. Dieterich; E. Laag; H. Schöpper; U. Volta; A. Ferguson; H. Gillett; E.O. Riecken; D. Schuppan (Dec 1998). "Autoantibodies to tissue transglutaminase as predictors of celiac disease". Gastroenterology. 115 (6): 1317–1321. doi:10.1016/S0016-5085(98)70007-1. PMID   9834256.
  3. W. Dieterich; T. Ehnis; M. Bauer; P. Donner; U. Volta; E.O. Riecken; D. Schuppan (Jul 1997). "Identification of tissue transglutaminase as the autoantigen of celiac disease". Nat Med. 3 (7): 797–801. doi:10.1038/nm0797-797. PMID   9212111. S2CID   20033968.
  4. Y. Junker; S. Zeissig; S.J. Kim; D. Barisani; H. Wieser; D.A. Leffler; V. Zevallos; T.A. Libermann; S. Dillon; T.L. Freitag; C.P. Kelly; D. Schuppan (Dec 2012). "Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4". The Journal of Experimental Medicine. 209 (13): 2395–2408. doi:10.1084/jem.20102660. PMC   3526354 . PMID   23209313.
  5. ARD Mittagsmagazin: Beitrag: Protein "ATI" in Weizen macht krank. on YouTube (in German) Retrieved 11 July 2014
  6. M. Kornek; Y. Popov; T.A. Libermann; N.H. Afdhal; D. Schuppan (Jan 2011). "Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells". Hepatology. 53 (1): 230–242. doi:10.1002/hep.23999. PMC   3505073 . PMID   20979056.
  7. M. Kornek; M. Lynch; S.H. Mehta; M. Lai; M. Exley; N.H. Afdhal; D. Schuppan (Aug 2012). "Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis". Gastroenterology. 143 (2): 448–458. doi:10.1053/j.gastro.2012.04.031. PMC   3404266 . PMID   22537612.
  8. PubMed: Scientific publications Schuppan. Retrieved 11 July 2014
  9. German Celiac Society: Members of the Scientific Council. Archived 2014-07-24 at the Wayback Machine (in German). Retrieved 05 August 2014
  10. University of Mainz: ERC Advanced Grant Fibroimaging Retrieved 07 August 2014
  11. FZI: The involved scientists. Retrieved 07 August 2014